Skip to main content
Clinical Trials/NCT02742922
NCT02742922
Completed
Not Applicable

Multicenter RCT to Evaluate the Clinical and Cost-effectiveness of a Culturally Adapted Therapy (C-MAP) in Patients With a History of Self-harm

Pakistan Institute of Living and Learning7 sites in 1 country901 target enrollmentApril 27, 2016
ConditionsSelf Harm

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Self Harm
Sponsor
Pakistan Institute of Living and Learning
Enrollment
901
Locations
7
Primary Endpoint
Suicide Attempt Self Injury Interview SASII
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

To evaluate the clinical and cost-effectiveness of a culturally adapted therapy (C-MAP) in patients with a history of self-harm

Detailed Description

Suicide is a serious global public health issue, ranked amongst the leading causes of death in many countries. Most of these (75%) are in the low and middle income countries (LAMIC) and globally suicide is the second leading cause of death in young people 15-29 years of age. There is no official data on suicide from Pakistan, a conservative South Asian Islamic country with historically low suicide rates. Both suicide and attempted suicide are illegal acts, as well as socially and religiously condemned, however, there is accumulating evidence that suicide rates have been gradually increasing in Pakistan over the last few years. The culturally adapted psychological intervention C-MAP utilizes problem solving components within a brief intervention that can be widely utilized in clinical practice. Our previous pilot trial in Karachi shows the efficacy of CBT based intervention(C-MAP) in people who had recently self harmed.The findings from this work have highlighted the applicability of such an intervention to health services in Pakistan for patients who present after a self-harm episode

Registry
clinicaltrials.gov
Start Date
April 27, 2016
End Date
October 30, 2019
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Nusrat Husain

Chief Investigator

University of Manchester

Eligibility Criteria

Inclusion Criteria

  • Patients over the age of 18 years will be considered eligible for the study.
  • Participants will have to be living within the catchment area of the participating practices and hospitals.
  • Not needing inpatient psychiatric treatment.

Exclusion Criteria

  • Temporary resident unlikely to be available for follow up.
  • Participants with ICD-I0 mental disorder; due to a general medical condition or substance misuse, dementia, delirium, alcohol or drug dependence, schizophrenia, bipolar disorder, learning disability.
  • Unable to engage, participate or respond to the research questionnaires.

Outcomes

Primary Outcomes

Suicide Attempt Self Injury Interview SASII

Time Frame: up to 12th months

Repetition rate of self-harm measured by adapted Suicide Attempt Self-Injury Interview (SASII)

Secondary Outcomes

  • Beck Scale for Suicidal ideation (BSI).(Baseline, 3, 6, 9 and 12th months)
  • Beck Hopelessness Scale(Baseline,3rd,6th,9th and 12th months)
  • Beck Depression Inventory (BDI)(Baseline,3rd,6th,9th and 12th months)
  • Coping Resource Inventory (CRI).(Baseline,3rd,6th,9th and 12th months)
  • Client Satisfaction Questionnaire (CSQ).(Baseline,3rd,6th,9th and 12th months)
  • EuroQol-5 Dimensions (EQ5-D)(Baseline,3rd,6th,9th and 12th months)

Study Sites (7)

Loading locations...

Similar Trials